Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2019 09:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

CHARLOTTESVILLE, Va., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for...
January 15, 2019 09:05 ET | Source: Adial Pharmaceuticals, Inc.

Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series

CHARLOTTESVILLE, Va., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of...
January 10, 2019 10:24 ET | Source: Adial Pharmaceuticals, Inc.

Update: Adial Pharmaceuticals to Present at The 2019 Wall Street Conference

CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
January 10, 2019 08:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals to Present at The 2019 Wall Street Conference

CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
December 24, 2018 08:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Retires All Outstanding Debt

CHARLOTTESVILLE, Va., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL;ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
December 19, 2018 09:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group

CHARLOTTESVILLE, Va., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
December 13, 2018 08:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl

CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
December 10, 2018 08:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder

CHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused on the development of...
November 29, 2018 09:10 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder

CHARLOTTESVILLE, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
November 21, 2018 08:00 ET | Source: Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals Chairman Featured in Doctors Channel Video Discussing Alcohol Use Disorder

CHARLOTTESVILLE, Va., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right